Gan HK, Cher L, Inglis PL, Lwin Z, et al. A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma. Clin Cancer Res 2026 Jun 10. doi: 10.1158/1078-0432.CCR-25-3608.
PMID: 42268288